Related Experiment Video

Updated: Jul 9, 2026

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?

Markus Bredel1, Claudia Bredel, Branimir I Sikic

  • 1Department of General Neurosurgery at the Neurocenter, University of Freiburg, Germany. mbredel@stanford.edu

The Lancet. Oncology
|February 6, 2004
PubMed

Insights

Chemotherapy offers limited benefit for brain tumors due to complex drug resistance. Further research into gene expression and genetic changes is crucial for improving patient outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Genomics
  • Pharmacology

Background:

  • Current chemotherapy regimens show limited efficacy in improving outcomes for most brain tumor patients.
  • While known resistance factors exist, they do not fully explain the poor clinical response to chemotherapy in brain tumors.
  • Brain tumors may possess unique genetic profiles influencing chemotherapy sensitivity.

Purpose of the Study:

  • To explore brain tumor-specific genetic factors contributing to chemotherapy resistance.
  • To investigate the complex network of regulatory dynamics involved in drug resistance.
  • To advance understanding of chemoresistance through comprehensive gene expression and genetic change characterization.

Main Methods:

  • Identification of known resistance-associated cellular factors in brain tumor models.
  • Analysis of gene expression profiles in brain tumors.
  • Characterization of genetic changes occurring during chemotherapy treatment.
  • Utilizing high-throughput bioanalytical methods for genome-wide studies.

Main Results:

  • Established resistance mechanisms are insufficient to account for the observed poor response to chemotherapy.
  • Evidence suggests that brain tumor-specific genetic profiles play a role in chemotherapy sensitivity.
  • Drug resistance in brain tumors likely involves a complex network of regulatory dynamics rather than single pathways.

Conclusions:

  • Existing chemotherapy approaches have a limited impact on brain tumor treatment outcomes.
  • Understanding the intricate genetic landscape and dynamic regulatory networks is essential for overcoming chemoresistance.
  • Novel research models combining hypothesis generation and functional testing are paving the way for future therapeutic strategies.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...